Concepedia

Author

Masakuni Tateyama

Kumamoto UniversityORCID

Also Known As

M. Tateyama, Masakuni Tateyama

38

Publications

501

Citations

9

H-Index

17

Concepts

All Affiliations

Kumamoto UniversityKumamoto University HospitalKumamoto City HospitalNagasaki International UniversityNagasaki Medical Center
MT

About

Masakuni Tateyama is an author at Kumamoto University specializing in pathology, hepatology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

112

2

Hepatology

2

2

112

3

Pathology

2

2

112

4

Health Sciences

1

1

25

5

Cancer Therapeutics

1

1

25

Masakuni Tateyama

×

8

Publications

421

Citations

8

H-Index

YearCitations

Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients

Kazumi Yamasaki, Masakuni Tateyama, Seigo Abiru,

Hepatology

2014

228

Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus

Masakuni Tateyama, Hiroshi Yatsuhashi, Naota Taura,

Journal of Gastroenterology

2010

87

Oral branched-chain amino acid granules improve structure and function of human serum albumin in cirrhotic patients

Hiroko Setoyama, Motohiko Tanaka, Kohei Nagumo,

Journal of Gastroenterology

2016

36

Evaluation of sorafenib treatment and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparative study using the propensity score matching method

Kotaro Fukubayashi, Motohiko Tanaka, Kazuhiro Izumi,

Cancer Medicine

2015

25

Loss of skeletal muscle mass affects the incidence of minimal hepatic encephalopathy: a case control study

Masakuni Tateyama, Hideaki Naoe, Motohiko Tanaka,

BMC Gastroenterology

2020

12

Comparison of endoscopic submucosal resection with ligation and endoscopic submucosal dissection for small rectal neuroendocrine tumors: A multicenter retrospective study

Kenshi Matsuno, Hideaki Miyamoto, Hideki Kitada,

DEN Open

2022

12

Modified albumin–bilirubin grade to predict eligibility for second-line therapies at progression on sorafenib therapy in hepatocellular carcinoma patients

Takayuki Tokunaga, Motohiko Tanaka, Kentaro Tanaka,

International Journal of Clinical Oncology

2021

11

Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter study

Masanori Atsukawa, Akihito Tsubota, Chisa Kondo,

Hepatology International

2022

10

Page 1